Verified earnings results
Generate Biomedicines Q3 2026 Earnings Results
Direct answer
Generate Biomedicines reported Q3 2026 results on November 12, 2026.
Revenue was 4,220,000. EPS missed the estimate by 19.76%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Generate Biomedicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 12, 2026
- Reported timing
- Before the US market opens
- EPS estimate
- -0.5678
- Reported EPS
- -0.68
- Revenue
- 4,220,000
- EPS surprise
- EPS missed the estimate by 19.76%.
Explore related company data
Read the frequently asked questions.
When did Generate Biomedicines report Q3 2026 earnings?
Generate Biomedicines reported on November 12, 2026. The reported timing was before the us market opens.
What is the available EPS estimate for Generate Biomedicines?
The verified record provides an EPS estimate of -0.5678.
Has Generate Biomedicines reported the Q3 2026 result?
Revenue was 4,220,000. EPS missed the estimate by 19.76%.
Which source supports this Generate Biomedicines earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.